SNB 101
Alternative Names: SN-38 - SN BioScience; SNB-101Latest Information Update: 02 Jan 2026
At a glance
- Originator SN BioScience
- Class Antineoplastics; Camptothecins; Indolizines; Pyrans; Quinolines; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Yes - Gastric cancer; Small cell lung cancer; Pancreatic cancer
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Breast cancer; Colorectal cancer; Gastric cancer; Head and neck cancer; Ovarian cancer; Pancreatic cancer; Small cell lung cancer; Solid tumours